Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,355 | 591 | 92.9% |
| Travel and Lodging | $962.31 | 3 | 6.7% |
| Education | $65.80 | 4 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $1,833 | 63 | $0 (2024) |
| Lilly USA, LLC | $1,349 | 62 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,322 | 56 | $0 (2024) |
| Amgen Inc. | $999.84 | 34 | $0 (2023) |
| PFIZER INC. | $684.21 | 41 | $0 (2024) |
| Esperion Therapeutics, Inc. | $666.65 | 22 | $0 (2024) |
| Merck Sharp & Dohme LLC | $664.29 | 40 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $637.27 | 44 | $0 (2022) |
| Penumbra, Inc. | $597.80 | 1 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $588.82 | 31 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,615 | 49 | Medtronic, Inc. ($364.51) |
| 2023 | $1,815 | 59 | Penumbra, Inc. ($597.80) |
| 2022 | $1,604 | 62 | AstraZeneca Pharmaceuticals LP ($297.28) |
| 2021 | $1,649 | 79 | AstraZeneca Pharmaceuticals LP ($270.71) |
| 2020 | $1,412 | 70 | E.R. Squibb & Sons, L.L.C. ($324.11) |
| 2019 | $1,642 | 84 | E.R. Squibb & Sons, L.L.C. ($284.46) |
| 2018 | $2,023 | 88 | Synergy Pharmaceuticals Inc ($382.28) |
| 2017 | $2,622 | 107 | Lilly USA, LLC ($335.85) |
All Payment Transactions
598 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: RESPIRATORY | ||||||
| 11/28/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: Oncology | ||||||
| 11/04/2024 | Medtronic, Inc. | IN.PACT ADMIRAL (Device) | Travel and Lodging | In-kind items and services | $359.94 | General |
| Category: Drug-Coated Balloons | ||||||
| 11/04/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/04/2024 | Medtronic, Inc. | IN.PACT ADMIRAL (Device) | Travel and Lodging | In-kind items and services | $4.57 | General |
| Category: Drug-Coated Balloons | ||||||
| 10/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/07/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: VACCINES | ||||||
| 10/07/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $3.06 | General |
| Category: VACCINES | ||||||
| 09/24/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/12/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/21/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $28.19 | General |
| Category: Cardiovascular | ||||||
| 08/19/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $17.93 | General |
| Category: Opioid Analgesic | ||||||
| 08/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Diabetes | ||||||
| 07/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: DIABETES | ||||||
| 07/22/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 07/15/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: VACCINES | ||||||
| 07/10/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Diabetes | ||||||
| 07/01/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: Oncology | ||||||
| 06/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Gastroenterology | ||||||
| 06/14/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/03/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/15/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $14.11 | General |
| Category: Opioid Analgesic | ||||||
| 05/13/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $17.46 | General |
| Category: Opioid Analgesic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 2,402 | 4,214 | $586,597 | $228,072 |
| 2022 | 20 | 2,671 | 4,346 | $617,987 | $238,664 |
| 2021 | 17 | 2,259 | 4,000 | $518,929 | $229,397 |
| 2020 | 17 | 2,224 | 3,802 | $469,345 | $201,289 |
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 376 | 911 | $136,650 | $71,176 | 52.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 333 | 333 | $83,250 | $50,773 | 61.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 147 | 149 | $149,000 | $26,451 | 17.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 156 | 188 | $37,600 | $19,515 | 51.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 428 | 994 | $74,550 | $12,633 | 16.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 139 | 139 | $20,850 | $11,579 | 55.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 387 | 834 | $8,340 | $7,006 | 84.0% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 40 | 160 | $17,280 | $6,925 | 40.1% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 25 | 29 | $8,650 | $5,605 | 64.8% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 68 | 68 | $16,847 | $3,446 | 20.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 135 | 135 | $13,500 | $2,981 | 22.1% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 50 | 53 | $4,505 | $2,665 | 59.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $4,050 | $2,600 | 64.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 25 | 25 | $3,000 | $1,891 | 63.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $2,600 | $1,125 | 43.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 25 | 75 | $3,750 | $867.24 | 23.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 15 | $1,050 | $758.38 | 72.2% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 25 | 75 | $1,125 | $78.57 | 7.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 361 | 361 | $90,250 | $56,189 | 62.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 354 | 687 | $102,000 | $51,894 | 50.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 153 | 154 | $154,000 | $29,111 | 18.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 190 | 251 | $49,775 | $25,596 | 51.4% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2022 | 14 | 14 | $21,000 | $11,988 | 57.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 443 | 945 | $70,875 | $11,564 | 16.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 89 | 89 | $20,025 | $11,121 | 55.5% |
About Dr. Aaron Greenberg, M.D
Dr. Aaron Greenberg, M.D is a Cardiovascular Disease healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376514786.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aaron Greenberg, M.D has received a total of $14,383 in payments from pharmaceutical and medical device companies, with $1,615 received in 2024. These payments were reported across 598 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($13,355).
As a Medicare-enrolled provider, Greenberg has provided services to 9,556 Medicare beneficiaries, totaling 16,362 services with total Medicare billing of $897,423. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Brooklyn, NY
- Active Since 02/01/2006
- Last Updated 05/01/2008
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1376514786
Products in Payments
- ELIQUIS (Drug) $1,985
- FARXIGA (Drug) $1,085
- Livalo (Drug) $637.27
- Repatha (Biological) $612.70
- Indigo System (Device) $597.80
- NEXLETOL (Drug) $553.01
- ENTRESTO (Drug) $521.26
- TRULICITY (Drug) $477.56
- JARDIANCE (Drug) $453.94
- Erleada (Drug) $440.93
- Trulance (Drug) $382.28
- IN.PACT ADMIRAL (Device) $364.51
- VERQUVO (Drug) $349.80
- Corlanor (Drug) $334.24
- XARELTO (Drug) $327.79
- MOUNJARO (Drug) $324.97
- JANUVIA (Drug) $286.20
- Cologuard Collection Kit (Device) $203.75
- Victoza (Drug) $182.82
- Ozempic (Drug) $171.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Brooklyn
Dr. Felix Yang, M.d, M.D
Cardiovascular Disease — Payments: $599,451
Ozgen Dogan, Md, MD
Cardiovascular Disease — Payments: $367,116
Dr. Adam Budzikowski, M.d., Ph.d, M.D., PH.D
Cardiovascular Disease — Payments: $346,063
Dr. Peter Rouvelas, M.d, M.D
Cardiovascular Disease — Payments: $339,378
Dr. Ronald Wharton, M.d, M.D
Cardiovascular Disease — Payments: $298,083
Dr. Sorin Brener, Md, MD
Cardiovascular Disease — Payments: $225,799